Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesTitration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency
European Journal of Pediatrics, 05/18/09
Ucar SK et al. - Betaine therapy was given for 2 years to a 2-year-old boy with 5,10-methylenetetrahydrofolate reductase deficiency. Used as a methyl donor to lower homocysteine levels through methylation of methionine, betaine has been reported to be effective in treating homocystinuria. Satisfactory biochemical and clinical responses were obtained with the following regimen: betaine started in the newborn period at increasing doses to reach 1 g given six times a day. It is suggested that frequent administration of a moderate dose may provide clinical and biochemical benefit.
Today in Child/Adolescent Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Sleep problems as reported by parents in Swedish children and adolescents with obsessive-compulsive disorder (OCD), child psychiatric outpatients and school children
Nordic Journal of Psychiatry, 12/10/09
Childhood trauma and dissociation in women with pseudoseizure-type conversion disorder
Nordic Journal of Psychiatry, 12/08/09
Risk of Death by Unnatural Causes During Early Childhood in Offspring of Parents With Mental Illness
American Journal of Psychiatry, 12/08/09
Sponsor
Article Search
Sponsor